ArticleInvestigative ophthalmology & visual science2025
Clinical and Biochemical Characterization of Specific GUCY2D Alleles Associated With a Rare Form of Night Blindness.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Purpose: To clinically and biochemically characterize a rare autosomal recessive rod-cone dysfunction, with electroretinographic similarities to some forms of stationary night blindness (SNB), associated with biallelic variants in GUCY2D. Methods: Six patients from five families with a history of longstanding night blindness, no fundus features suggestive of retinitis pigmentosa, and an unusual electroretinographic phenotype were ascertained. Clinical examination and genotyping were performed. Selected GUCY2D variants were tested for binding to and activation by guanylate cyclase-activating proteins (GCAPs) in HEK293 cells. Results: The visual acuity was normal or moderately reduced (20/20-20/60) with three patients having a tritan defect on color vision testing. Retinal imaging showed central macular hypopigmentation with temporal vascular attenuation. Rod photoreceptor-mediated electroretinogram (ERG) components were undetectable or severely reduced in all but one case, and cone-mediated responses were variable. A high degree of ERG stability was demonstrated in three cases. Molecular analyses revealed biallelic variants of GUCY2D in all patients, four of which are clinically and biochemically characterized for the first time, to our knowledge. These allelic variants encoded retinal guanylyl/guanylate cyclase 1 (RetGC1) mutants whose enzymatic activities were significantly diminished due to drastically reduced affinity of RetGC1 for GCAPs. Conclusions: The apparent lack of retinal degeneration, clinical features, predominant and severe rod photoreceptor involvement, and relatively high degree of ERG stability are similar to rare forms of SNB. Biallelic disease-causing variants in GUCY2D are usually associated with Leber's congenital amaurosis (LCA); however, this study illustrates the phenotypic variability of GUCY2D retinopathies in association with variants not biochemically dissimilar to those causing LCA and highlights the complexity of RetGC1 regulation in rod and cone photoreceptor function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.